πŸ‡ΊπŸ‡Έ FDA
Patent

US 7226950

Sodium channel modulators

granted A61KA61K31/135A61K31/401

Quick answer

US patent 7226950 (Sodium channel modulators) held by Theravance, Inc. expires Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jun 05 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/135, A61K31/401, A61K31/4152, A61K31/417